ELI LILLY AND COMPANY ACCELERATES CHINA EXPANSION
AsiaInfo Services, December, 2005
AsiaInfo Services 12-20-2005 Eli Lilly and Company Accelerates China Expansion CHINA, Dec 20, 2005 (SinoCast via COMTEX) -- Eli Lilly and Company, which has not shaken off the Gemzar lawsuit, presented a new cancer drug Alimta in China recently. The Indianapolis-based pharmaceutical company will chiefly expand in the Chinese anti-tumor drug market, said Dr.
Jorg Ostertag, president for Lily China. Gemzar, a nucleoside used as chemotherapy, has come atop amongst anti-tumor drug products in 2004, but the patent is presently accused of invalid and unenforceable. Chinese drugmakers will be able to produce generic drugs, provided that the Gemzar patent was judged to be invalid and unenforceable. The newly-debuted Alimta is the unique cancer drug used to...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
